Streetbeat News

Analyst Ratings

CWH

Stephens & Co. analyst Daniel Imbro has reiterated an Overweight rating on Camping World Holdings (NYSE:CWH) and maintained a $26 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:44 pm

SEDG

SolarEdge Technologies, Inc. (SEDG) shares have declined following a downgrade by Barclays from Equal-Weight to Underweight, accompanied by a reduction in the price target from $74 to $50.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:44 pm

CVGW

Stephens & Co. analyst Ben Bienvenu has reiterated an Equal-Weight rating on Calavo Growers (NASDAQ:CVGW) and maintained a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:42 pm

RIVN

Rivian Automotive's stock (RIVN) trades lower following a downgrade by Deutsche Bank from Buy to Hold and a reduction in the price target from $29 to $19.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:40 pm

FBK

Stephens & Co. analyst Matt Olney has maintained an Equal-Weight rating on FB Financial (NYSE:FBK) but reduced the price target from $45 to $41.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:39 pm

HWC

Stephens & Co. analyst Matt Olney has maintained an Equal-Weight rating on Hancock Whitney (NASDAQ:HWC) but has reduced the price target from $55 to $50.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:36 pm

KNTE

Wedbush analyst David Nierengarten has reiterated a Neutral rating on Kinnate Biopharma (NASDAQ:KNTE) and maintained a price target of $2.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:32 pm

RCUS

Wedbush analyst Robert Driscoll has reiterated an Outperform rating on Arcus Biosciences (NYSE:RCUS) and maintained a price target of $36. This reaffirmation of the stock's potential could influence investor sentiment and stock performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:24 pm

AMPH

BDX

BNTX

LMT

MRNA

PAAS

STWD

Jim Cramer, on CNBC's 'Mad Money Lightning Round,' recommended holding onto Moderna (MRNA) and BioNTech (BNTX), citing their inexplicably low prices and leadership. He suggested Becton, Dickinson (BDX) over Amphastar Pharmaceuticals (AMPH) for stability. Cramer praised Pan American Silver (PAAS) as the top silver company and endorsed Starwood Property Trust (STWD) for its dividend. He was bullish on Lockheed Martin (LMT), simply advising to 'just buy it.' The article also reports recent price actions of these stocks.

Portfolio Pulse from Avi Kapoor

January 17, 2024 | 1:22 pm

SKX

Wedbush analyst Tom Nikic has maintained an Outperform rating on Skechers USA (NYSE:SKX) and increased the price target from $62 to $75, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:22 pm